Depersonalization/Derealization Disorder

Clinical picture

• Depersonalization is experienced as observing one's own thoughts, body, or actions from outside, with emotional numbing and a sense of not being real.
• Derealization renders surroundings dreamlike, foggy, flat, or visually distorted, with familiar people and places feeling artificial or stage-set.
• Reality testing stays intact throughout: patients say it is as if they were unreal, which cleanly separates the condition from psychosis.
• Subjective memory and concentration complaints, distorted time sense, and a feeling that one's own past belongs to someone else are frequent.
• Onset is often abrupt after cannabis, ketamine, or hallucinogen use, a panic attack, or severe stress, and patients recall the exact moment it began.
• Patients describe the state as indescribable, fear they are going insane, and typically see several clinicians over years before it is correctly named.

Criteria snapshot

• Persistent or recurrent experiences of depersonalization, derealization, or both, which may occur separately or together in the same person.
• Reality testing is preserved during the experiences, distinguishing the disorder from psychotic conditions in which unreality is held as delusional belief.
• The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
• Not attributable to a substance, medication, seizure disorder, or another medical condition, requiring history, toxicology, and sometimes EEG to exclude.
• Not better explained by schizophrenia, panic disorder, major depression, acute stress disorder, PTSD, or another dissociative disorder.

Neurobiology

• The fronto-limbic model holds that ventrolateral and dorsolateral prefrontal cortex over-inhibit amygdala and anterior insula, stripping experience of emotional coloring.
• Autonomic reactivity to aversive stimuli is reduced, with attenuated skin conductance responses despite normal or elevated subjective anxiety.
• Anterior insula hypoactivation disrupts interoceptive awareness, plausibly generating the disembodied, numbed quality that patients struggle to describe.
• NMDA antagonism reproduces the syndrome, since ketamine reliably induces it, and cannabis and hallucinogens are the most common clinical precipitants.
• HPA axis findings include blunted cortisol reactivity and altered feedback sensitivity, a pattern distinct from that seen in PTSD and major depression.
• Temporoparietal junction dysfunction in multisensory integration links the disorder to out-of-body phenomena and is the target of rTMS research.

Psychology

• Catastrophic appraisal of ordinary dissociative sensations drives the maintenance cycle, as symptom monitoring and threat interpretation amplify unreality.
• Depersonalization begins as an evolved defense that dampens overwhelming affect to preserve function under threat, then persists past any usefulness.
• Safety behaviors such as checking oneself in mirrors, avoiding crowds or bright light, and constant self-scrutiny maintain symptoms much as in panic disorder.
• Childhood emotional neglect and verbal abuse are the adversity types most consistently associated with the disorder, more than physical or sexual trauma.
• Rumination about the nature of self and existence consumes attention and correlates with severity on the Cambridge Depersonalisation Scale.

Differential & comorbidity

• Panic disorder commonly includes depersonalization during attacks; a separate diagnosis applies only when unreality persists outside panic episodes.
• Substance-induced states from cannabis, ketamine, hallucinogens, or withdrawal resolve with abstinence, while persistence supports the primary disorder.
• Temporal lobe epilepsy, migraine, vestibular disease, and traumatic brain injury all produce derealization and warrant EEG or imaging when features are atypical.
• Depression and anxiety disorders are the leading comorbidities, present in the majority, and depersonalization predicts poorer antidepressant response.
• Suicidal ideation is common and driven by intolerable emptiness rather than depressed mood, so screen even when the mood exam looks unremarkable.

Pharmacologic treatment

• No agent is FDA-approved; SSRIs alone did not outperform placebo in controlled trial and are reserved for comorbid depression or anxiety.
• Lamotrigine 100-250 mg/day added to an SSRI carries the most supportive open-label and small controlled data, presumably through glutamate modulation.
• Naltrexone 50-100 mg/day produced modest benefit in open trials, consistent with an endogenous opioid contribution to dissociative numbing.
• Clonazepam combined with an SSRI may help when anxiety drives symptoms, but benzodiazepines deepen dissociation and should not become standing therapy.
• Full cessation of cannabis, stimulants, and hallucinogens is non-negotiable, since continued use sustains symptoms and defeats every other intervention.

Psychotherapy

• CBT targeting catastrophic appraisals, symptom monitoring, and safety behaviors is the best-supported psychotherapy, with meaningful gains in open trials.
• Psychoeducation and normalization alone reduce distress substantially, because much of the suffering comes from fear of insanity or brain damage.
• Behavioral experiments drop reality checking and self-scrutiny, while attention training redirects focus outward onto external tasks and sensory detail.
• Trauma-focused work is indicated when childhood emotional neglect or abuse is prominent, sequenced after stabilization and appraisal work.
• Mindfulness and acceptance-based approaches teach non-judgmental observation of unreality, reducing the struggle that perpetuates the state.

Adjunct options

• Quantify severity and change with the Cambridge Depersonalisation Scale or the depersonalization subscale of the DES-II at regular intervals.
• rTMS to the right temporoparietal junction reduced symptoms in small open studies and remains investigational rather than routine care.
• Regular aerobic exercise, consistent sleep, and reduced caffeine lower baseline autonomic arousal and measurably lessen symptom intensity.
• Correct fatigue, dehydration, and hyperventilation, all of which acutely intensify unreality and often explain day-to-day fluctuation in severity.
• Peer support and accurate patient resources counter the isolation of a condition patients cannot describe to family or to previous clinicians.

Clinical pearls

• Intact reality testing separates this from psychosis: it feels as if, it is never believed to be.
• Ask directly; patients rarely volunteer symptoms they fear will sound insane.
• Cannabis is the most common trigger and the most common reason it persists.